Skip to content

Clinical trials

Myasthenia Gravis trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myasthenia Gravis Country / region: United Kingdom Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20081
20131
20141
20181
20196
20213
20223
20233
202412
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Recruiting10
Active, not recruiting9
Terminated4
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
UCB Biopharma SRL6
argenx6
Alexion Pharmaceuticals, Inc.5
Novartis Pharmaceuticals3
Immunovant Sciences GmbH2
Momenta Pharmaceuticals, Inc.2
Vitaccess Ltd2
Ad scientiam1
Amgen1
Cartesian Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myasthenia Gravis39
Autoimmune Diseases3
Atypical Hemolytic Uremic Syndrome1
Autoimmune Diseases of the Nervous System1
Diabetes Mellitus1
Heart Failure1
Hemoglobinuria, Paroxysmal1
Hypertension1
Multiple Sclerosis1
Nervous System Diseases1

Trials

Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.